Drug Test Detects 7 Drugs On Surfaces Or Powders Screen Dro

Instructions for use for each test combination to test for any combination of the following drugs: Cocaine, Marijuana / THC, Methamphetamine, Amphetamine, Ketamine, MDMA / Ecstasy, Morphine.

PRECAUTIONS
• Product not intended for diagnostic use.
• Do not use after the expiration date.
• Store the test in the sealed pouch until use.
• All samples must be considered potentially dangerous and therefore must be handled with the precautions for use relating to potentially infectious products.
• After use, the panel must be disposed of according to local regulations in force.
Store in the packaging at a temperature between 2 ° and 30 ° C.
The test is stable until the expiration date indicated on the package label.
The test should be kept in the closed pouch until use.
Do not freeze.
Do not use beyond the expiration date.

INTENDED USE AND SUMMARY
Rapid chromatographic immunoassay for the qualitative detection of multiple drugs and metabolites on surfaces and solids at the following cut-off concentrations:

Test	Calibrator	Threshold-limit (ng / mL)
Amphetamine (AMP)	d-Amphetamine	1000
Cocaine (COC)	Benzoylecgonine	300
Marijuana (THC)	11-nor-Δ9-THC-9 COOH	50
Methamphetamine (MET)	d- Methamphetamine	1000
Methylenedioxymethamphetamine (MDMA)	d, l- Methylenedioxymethamphetamine	500
Morphine (MOP)	Morphine	300
Ketamine (KET)	Ketamine	1000

Product not intended for medical diagnostic use.
This test provides only a preliminary analytical result.
A more specific alternative chemical method will need to be used to obtain a confirmatory analytical result.
Medical judgment and professional opinion will be needed to evaluate any drug of abuse test, particularly when these indicate positive preliminary results.

SUMMARY
The Rapid Screen Drug Test is a rapid surface or solid test that can be performed without the use of instrumentation.
The test uses monoclonal antibodies to selectively detect elevated levels of specific drugs on surfaces and solids.

Amphetamine (AMP)
Amphetamine is a Schedule II substance of the American DEA sold by prescription (Dexedrine) and also available illegally on the market. Amphetamines are a class of potent sympathomimetic agents with therapeutic functions. They are chemically linked to two catecholamines naturally produced by the human body: epinephrine and norepinephrine. High acute doses induce central nervous system stimulation and cause euphoria, alertness, decreased appetite and a sense of increased energy and power. Cardiovascular reactions to amphetamines include increased blood pressure and cardiac arrhythmias. More acute reactions cause anxiety, paranoia, hallucinations and psychotic behavior.

Cocaine (COC)
Cocaine is a powerful central nervous system stimulant and a local anesthetic. It initially causes extreme energy and restlessness, which gradually becomes tremor, hypersensitivity and spasms.
Cocaine, taken in high doses, causes fever, loss of sensation, difficulty in breathing and loss of consciousness.
Cocaine is often self-administered by nasal inhalation, intravenous injection and free-base smoking.

Marijuana (THC)
THC (Δ9-tetrahydrocannabinol) is the main active ingredient in cannabis (marijuana).
When smoked or administered orally, THC produces euphoria.
Those who use it have short-term memory damage and slow learning.
You may also experience transient episodes of confusion and anxiety.
Relatively heavy and long-term use may be associated with behavioral disturbances.
The peak effect of smoking marijuana occurs within 20-30 minutes and lasts 90-120 minutes after a cigarette.

Methamphetamine (MET)
Methamphetamine is a stimulant drug that energetically activates certain brain systems.
Methamphetamine is very similar chemically to amphetamine, but its effects on the central nervous system are greater.
Methamphetamine is produced in illegal laboratories and has a high potential for abuse and addiction.
The drug can be taken orally, injected or inhaled.
High acute doses induce excessive stimulation of the central nervous system, euphoria, lucidity, reduced appetite and a sense of increased energy and power.
Cardiovascular reactions to methamphetamine include increased blood pressure and cardiac arrhythmias.
More acute reactions cause anxiety, paranoia, hallucinations, psychotic behavior, and ultimately depression and exhaustion.

Ecstasy (MDMA)
Methylenedioxymethamphetamine (ecstasy) is a synthetic drug first synthesized in 1914 by a German pharmaceutical company for the treatment of obesity.
Those who take it frequently have experienced side effects, such as increased muscle tension and sweating.
MDMA is clearly not a stimulant, although it has the ability to increase blood pressure and heart rate in common with amphetamine.
MDMA produces some changes in perception by increasing sensitivity to light, difficulty concentrating and blurred vision in some people. Its mechanism of action is thought to be via the neurotransmitter serotonin.
MDMA can also release dopamine, although the general opinion is that this is a side effect of the drug (Nichols and Oberlender, 1990).
The main effect of MDMA, which has likely occurred in anyone who has taken a reasonable dose, is to produce a contraction of the jaws.

Morphine (MOP)
The term opiate refers to any substance derived from the opium poppy, including natural products, morphine, codeine, and semi-synthetic drugs such as heroin.
The term opioid is more generic and refers to any drug that acts as an opioid receptor.
Opioid analgesics comprise a large group of substances that control pain by sedating the central nervous system.
High doses of morphine can produce high levels of tolerance, physiological dependence and can lead to substance abuse.
Morphine is eliminated without being metabolized and is also the major metabolic product of codeine and heroin.

Ketamine (KET)
Ketamine is a dissociative anesthetic developed in 1963 to replace PCP (Phencyclidine).
While Ketamine is still used in human and veterinary anesthesia, it is increasingly being abused as a drug.
Ketamine is molecularly similar to PCP and therefore creates similar effects including numbness, loss of coordination, a sense of invulnerability, muscle stiffness, aggressive / violent behavior, confused speech or aphasia, an exaggerated sense of strength and blank stare.
It has a depression of the respiratory function but not of the central nervous system and the cardiovascular function is maintained.

PRINCIPLE
During the test the sample migrates upwards by capillary action.
A drug, if present in the sample below the cut-off concentration, will not saturate the binding sites of this specific antibody.
The antibody will then react with the drug-protein conjugate and a colored line will appear visible in the test area for the specific drug tested.
The presence of the drug above the cut-off concentration will saturate all binding sites of the antibody.
Therefore the colored line will not form in the test area.
A positive sample will not generate a colored line in the specific test zone of the strip due to drug competition, while a negative drug sample will generate a line in the test zone due to the absence of competition.
For procedural control purposes, a colored line will always appear in the control zone, indicating that the correct volume of sample has been spilled and the membrane has been soaked.

REAGENTS
Each test line contains a guinea pig anti-drug monoclonal antibody and related drug-protein conjugates.
The control line contains polyclonal antibodies to rabbit IgG from goat and IgG from rabbit.

PRECAUTIONS
• Single use.
• Do not touch the free ends of the strips to avoid contamination.
• Do not immerse the support beyond the maximum level indicated.
• Immerse the test in the buffer until one or two red lines appear in the reaction zone (~ 15 seconds).
• Do not pour samples into the reaction zone.
• Samples can be potentially infectious. Establish appropriate disposal and handling methods.
• Do not use the Multi Drug device beyond the expiration date.
• Do not use the test if the package is damaged.
• Use the test immediately after opening it.
• Please take specificity and cross reactivity into account for the evaluation.
• Always store and transport the test device at 2-30 ° C.

STORAGE AND STABILITY
Store in the sealed original package at 2-30 ° C.
The test is stable until the expiration date printed on the package.
The test should remain in the sealed pouch until use.
Do not freeze.
Do not use beyond the expiration date.

MATERIALS PROVIDED
• Device.
• Package leaflet.
• Buffer.

MATERIALS REQUIRED BUT NOT PROVIDED
• Sample collection container.
• Timer.

Instructions for Use
The test device (in sealed packages), specimens and controls should be brought to room temperature (15-30 ° C) prior to testing.
Do not open the packages until you are ready to test.

FOR SURFACES
1. Pass the strips over the surface to be analyzed.
2. Remove the cappuccino from the bottle provided.
3. Pour all of the bottle buffer into the protective cap.
4. Insert the Multi Test slowly and carefully into the lid with the buffer.
5. Wait for the lines to appear on the membrane and read the results after 5 minutes. Do not interpret the results after 10 minutes.

FOR SOLIDS
1. Open the bottle and insert the solid into the buffer.
2. Close the bottle with dropper and cap. Shake it briefly. Wait 30 seconds.
3. Remove the cappuccino from the bottle ;.
4. Pour all the buffer with the dissolved substances into the protective cover.
5. Insert the Multi Test slowly and carefully into the protective cover with the buffer.
6. Wait for the lines to appear on the membrane and read the results after 5 minutes. Do not interpret the results after 10 minutes.

INTERPRETATION OF RESULTS
Negative *: a colored line appears in the Control area (C) and a colored line in the Test area (T). This negative result indicates that the concentrations in the sample are below the cut-off levels established for a particular drug tested.
* the hue of the colored line (s) in the test area (T) may vary. The result should be considered negative whenever even a faint line appears. Positive: a colored line appears in the Control area (C) and no line appears in the Test area (T). The positive result indicates that the drug concentration in the sample is greater than the cutoff threshold established for a specific drug.
Null: no line appears in the control area (C). The most likely reasons for the lack of a Control line are insufficient sample volume or incorrect procedural techniques. Read the instructions again and repeat the test. If the result is still null, contact the manufacturer.

QUALITY CHECK
A procedural control is included in the test.
The line appearing in the control region (C) is considered an internal procedural control.
Confirms that sufficient sample volume, adequate membrane imbibition and correct procedural technique were used.
Check standards are not provided with this kit.
However, testing positive and negative controls is recommended as a good laboratory practice to confirm the test procedure and its proper functioning.

LIMITATIONS
1. The Screen Drug Test Quick Test provides only a qualitative preliminary analytical result. A secondary analytical method should be used to confirm the result. The recommended confirmatory method is gas chromatography / mass spectrometry (GC / MS).
2. A negative result may not necessarily indicate a drug-free sample. Negative results may be obtained when the drug is present below the cut-off point for the test.
3. This test does not distinguish between drugs of abuse and some medications.

EXPECTED VALUES
The negative result indicates that the drug concentration is below the detection level.
A positive result indicates that the drug concentration is above the detection level.

FORMAT
• 1 bottle.
• 1 Dust Surface Test Drug.
• 1 package insert.